Restrictive dieting, whether part of a commercial weight plan or associated with GLP-1 medication usage, can sometimes lead to nutrient gaps that undermine energy and overall well-being
These findings suggest caution in short-term use of these drugs without a more comprehensive approach to weight management. In an associated editorial, Qi Sun, associate professor of medicine at Brigham and Womens Hospital and Harvard Medical School, highlighted that obesity is not a disease that can be easily treated and managed and that the BMJ study findings cast doubt on the notion that GLP-1 receptor agonists are a perfect cure
This article explains how common nausea is, why it occurs, how it can be managed, and when to seek medical advice drawing on published clinical evidence and UK regulatory guidance
BPC-157 was first isolated from body protection compound (BPC), which is found in the gastric juices and is part of the digestive process [1]
While clinical trials have shown Semaglutide can lead to significant weight loss, the amount of weight you can expect to lose depends on several factors, including your: Starting weight Adherence to treatment Adherence to lifestyle changes Individual response to the medication It is important to stress that this medication is most effective as part of a comprehensive weight loss program that includes healthy eating, regular exercise, and several behavioral changes (e.g., goal setting, self-monitoring, and finding alternative coping mechanisms)